Script section containing code for Liveperson Chat Solution

Hoover's - A D&B Company - We Make It Easier
I'm Ready to Subscribe
Special Offers
DNBi. Leverage D&B's credit assessment tools.

QLT Inc. · Vancouver, BC Canada (Toronto: QLT)(NASDAQ: QLTI)

887 Great Northern Way,
Ste. 101
Phone: +1-604-707-7000
VancouverBCFax: +1-604-707-7001
V5T 4T5
CanadaMap Map This Company
  • Company Profiles
  • Competitive Landscapes
  • Industry Reports

Buy Reports

For a Hoover's Free Trial, Call
(866) 444-8642
or
Chat Now

QLT Inc. Rankings

Company Description

QLT's drugs respond to a light touch. The company develops pharmaceuticals that are activated when exposed to light. Its main product Visudyne, developed and marketed with Novartis' ophthalmic division, fights a type of age-related macular degeneration (AMD), a leading cause of blindness. Visudyne is administered through a two-stage intravenous and laser treatment process. The drug is approved in more thanĀ 80 countries. The company hopes to expand Visudyne's indications for other types of AMD. QLT is also developing additional ophthalmology therapies for ailments including glaucoma, ocular hypertension, and allergic conjunctivitis.

To read the full description: Subscribe Now
left-headQLT Inc. Reports
right-head

No subscription, no problem.

Download presentation-ready reports. From company profiles to the competitive landscape, Hoover's offers immediate access to individual reports.

Shop Reports
Shop Reports

Financials

Company TypePublic - NASDAQ: QLTI Headquarters
Fiscal Year-EndDecember
2010 Employees172
More QLT Inc. Financials

Executives

13 executives listed for QLT Inc.'s Vancouver, BC location.

ChairmanC. Boyd ClarkeE-mail
President, CEO, and DirectorRobert ButchofskyE-mail
VP Finance and CFOCameron NelsonE-mail

More QLT Inc. Executives

Sponsored Links